# Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates

> **NCT00599053** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 7 (actual)

## Conditions studied

- Bacteria Infection
- Respiratory Tract Infections

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00599053
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Enrollment was terminated early due to a change in practice on the obstetrical side that included administering azithromycin to women with preterm labor.
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599053, "Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00599053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*